Discovery of Broadly Neutralizing Antibodies (bNAbs) has given a great boost to HIV vaccine research. Study of bNAbs capable of neutralizing a broad array of different HIV strains is important for a number of reasons: (i) structures of antigens co-crystallized with bNAbs are used as templates in HIV vaccine design; (ii) bNAbs can be effective as therapeutics; (iii) preventive use of bNAbs is a promising direction in AIDS care. The goal of bNAber is to collect, analyze, compare and present bNAbs data, thus helping researchers to create HIV vaccine.
Search for anti-HIV bNAbs that fit the following criteria. All criteria are combined to create the resulting dataset.
Select Ab based on gp160 biding site:
Image used with permission from Cell Host Microbe.
Two more instructional videos have been added to bNAber video collection:
How to build neutralization heatmaps in bNAber and
How to compare bNAbs sequences and structures (1D and 3D)
Click here to view the video tutorials
bNAbs to Flu
Recently, discovery of broadly neutralizing antibodies to influenza virus has identified two major supersites of vulnerability on the influenza virus hemagglutinin, one involved in receptor binding and the other, in fusion machinery.
3BNC117 first-in-man trial
Antibody-based drug against HIV was for the first time tested in humans – see here.
www.bNAber.org | 2013 | | A member of | Page accessed on November 30, 2015, 12:41 PM | Contact Us
bNAber is a database, analysis, visualization, and data discovery tool for broadly neutralizing HIV-1 antibodies (bNAbs), and seeks to be a vital tool in the search for an AIDS vaccine.